ArticleNeuro-oncology2021

Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel?

Vijay Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.